1. Home
  2. IMMX vs AGBK Comparison

IMMX vs AGBK Comparison

Compare IMMX & AGBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Immix Biopharma Inc.

IMMX

Immix Biopharma Inc.

N/A

Current Price

$7.92

Market Cap

784.8M

Sector

Health Care

ML Signal

N/A

Logo AGI Inc Class A Common Shares

AGBK

AGI Inc Class A Common Shares

N/A

Current Price

$6.33

Market Cap

823.2M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
IMMX
AGBK
Founded
2014
1999
Country
United States
Brazil
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Commercial Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
784.8M
823.2M
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
IMMX
AGBK
Price
$7.92
$6.33
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
11
Target Price
★ $24.05
$10.47
AVG Volume (30 Days)
★ 1.2M
563.9K
Earning Date
11-12-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$58.64
Revenue Next Year
N/A
$35.59
P/E Ratio
★ N/A
$46.19
Revenue Growth
N/A
N/A
52 Week Low
$3.78
$4.43
52 Week High
$15.10
$12.21

Technical Indicators

Market Signals
Indicator
IMMX
AGBK
Relative Strength Index (RSI) 42.67 57.80
Support Level $7.82 $5.91
Resistance Level $9.04 $7.59
Average True Range (ATR) 0.62 0.40
MACD 0.16 0.12
Stochastic Oscillator 41.81 93.71

Price Performance

Historical Comparison
IMMX
AGBK

About IMMX Immix Biopharma Inc.

Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.

About AGBK AGI Inc Class A Common Shares

AGI Inc is a technology-powered provider of specialized financial services in Brazil. It empowers clients to access their social security benefits, severance fund benefits, and public or private sector payrolls through secured lending solutions and complementary banking, credit and insurance products tailored as per client needs. The company has one operating segment related to the banking business. The Bank provides a standardized set of financial products and services exclusively to individuals, mainly focused on credit, including digital accounts, cards, payroll and personal loans, and insurance offered through partners.

Share on Social Networks: